CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
16.36
+1.00 (6.51%)
At close: May 12, 2025, 4:00 PM
16.20
-0.16 (-0.98%)
After-hours: May 12, 2025, 5:47 PM EDT
CareDx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 346.42 | 333.79 | 280.32 | 321.79 | 296.4 | 192.19 | Upgrade
|
| Revenue Growth (YoY) | 25.92% | 19.07% | -12.89% | 8.57% | 54.22% | 51.25% | Upgrade
|
| Cost of Revenue | 112.11 | 109.63 | 102 | 112.21 | 97.39 | 63.12 | Upgrade
|
| Gross Profit | 234.31 | 224.16 | 178.33 | 209.58 | 199.01 | 129.08 | Upgrade
|
| Selling, General & Admin | 201.29 | 205.5 | 200.5 | 196.42 | 152.21 | 102.66 | Upgrade
|
| Research & Development | 72.22 | 72.41 | 81.87 | 90.39 | 76.53 | 48.94 | Upgrade
|
| Operating Expenses | 273.51 | 277.91 | 282.37 | 286.81 | 228.73 | 151.61 | Upgrade
|
| Operating Income | -39.2 | -53.75 | -104.04 | -77.23 | -29.73 | -22.53 | Upgrade
|
| Interest & Investment Income | 11.66 | 11.77 | 11.87 | 3.76 | 1.29 | 0.27 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.61 | 0.03 | -0.15 | -2.77 | -0.78 | -2.31 | Upgrade
|
| EBT Excluding Unusual Items | -26.92 | -41.96 | -92.32 | -76.23 | -29.22 | -24.56 | Upgrade
|
| Merger & Restructuring Charges | -1.78 | -1.78 | -3.02 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.3 | 0.3 | 1.5 | - | -2.87 | - | Upgrade
|
| Legal Settlements | 90.94 | 96.3 | -96.3 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 4.81 | Upgrade
|
| Pretax Income | 62.54 | 52.86 | -190.14 | -76.23 | -32.09 | -19.75 | Upgrade
|
| Income Tax Expense | 0.45 | 0.31 | 0.14 | 0.38 | -1.43 | -1.04 | Upgrade
|
| Earnings From Continuing Operations | 62.08 | 52.55 | -190.28 | -76.61 | -30.66 | -18.71 | Upgrade
|
| Net Income | 62.08 | 52.55 | -190.28 | -76.61 | -30.66 | -18.71 | Upgrade
|
| Net Income to Common | 62.08 | 52.55 | -190.28 | -76.61 | -30.66 | -18.71 | Upgrade
|
| Shares Outstanding (Basic) | 54 | 53 | 54 | 53 | 52 | 46 | Upgrade
|
| Shares Outstanding (Diluted) | 58 | 57 | 54 | 53 | 52 | 46 | Upgrade
|
| Shares Change (YoY) | 7.95% | 5.31% | 0.83% | 2.07% | 12.39% | 10.27% | Upgrade
|
| EPS (Basic) | 1.16 | 1.00 | -3.54 | -1.44 | -0.59 | -0.40 | Upgrade
|
| EPS (Diluted) | 1.07 | 0.93 | -3.54 | -1.44 | -0.59 | -0.40 | Upgrade
|
| Free Cash Flow | 20.15 | 31.56 | -26.73 | -46.47 | -32.85 | 26.32 | Upgrade
|
| Free Cash Flow Per Share | 0.35 | 0.56 | -0.50 | -0.87 | -0.63 | 0.57 | Upgrade
|
| Gross Margin | 67.64% | 67.16% | 63.61% | 65.13% | 67.14% | 67.16% | Upgrade
|
| Operating Margin | -11.32% | -16.10% | -37.11% | -24.00% | -10.03% | -11.72% | Upgrade
|
| Profit Margin | 17.92% | 15.74% | -67.88% | -23.81% | -10.35% | -9.74% | Upgrade
|
| Free Cash Flow Margin | 5.82% | 9.46% | -9.54% | -14.44% | -11.08% | 13.69% | Upgrade
|
| EBITDA | -25.23 | -39.56 | -89.66 | -65.64 | -20.93 | -15.52 | Upgrade
|
| EBITDA Margin | -7.28% | -11.85% | -31.98% | -20.40% | -7.06% | -8.08% | Upgrade
|
| D&A For EBITDA | 13.97 | 14.19 | 14.39 | 11.6 | 8.8 | 7.01 | Upgrade
|
| EBIT | -39.2 | -53.75 | -104.04 | -77.23 | -29.73 | -22.53 | Upgrade
|
| EBIT Margin | -11.32% | -16.10% | -37.11% | -24.00% | -10.03% | -11.72% | Upgrade
|
| Effective Tax Rate | 0.72% | 0.59% | - | - | - | - | Upgrade
|
| Revenue as Reported | 346.42 | 333.79 | 280.32 | 321.79 | 296.4 | 192.19 | Upgrade
|
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.